vers la météo de la validation par utilisateur
+----------------------COMP:V-N(from)----------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------COMP:V-N(from)----------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ | +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ | +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +----------------------COMP:V-N(from)----------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +----------------------COMP:V-N(from)----------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------COMP:V-N(from)----------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ | +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------COMP:V-N(from)----------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ | +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +-----------------COMP:V-N(in)-----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +-----------------COMP:V-N(in)-----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +-----------------COMP:V-N(in)-----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +-----------------COMP:V-N(in)-----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+-----------------COMP:N-N(from)----------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+-----------------COMP:N-N(from)----------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +------------COMP:N-N(in)-----------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +------------COMP:N-N(in)-----------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------COMP:V-N(from)----------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------COMP:V-N(from)----------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-----------------COMP:N-N(from)----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-----------------COMP:N-N(from)----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +------------COMP:N-N(in)-----------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +------------COMP:N-N(in)-----------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-----------------COMP:N-N(from)----------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-----------------COMP:N-N(from)----------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+ +-----------------COMP:N-N(from)----------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+ +-----------------COMP:N-N(from)----------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ | +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ | +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +-----------------COMP:N-N(from)----------------+ | | | +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +-----------------COMP:N-N(from)----------------+ | | | +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +COMP:N-N(o+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,week) MOD_ATT:N-ADJ (week,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +----------------------COMP:V-N(from)----------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +----------------------COMP:V-N(from)----------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:V-N(in)-----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------COMP:V-N(from)----------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ | +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------COMP:V-N(from)----------------------+ +----------------------------------COMP:V-N(in)---------------------------------+ | +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +-----------------COMP:V-N(in)-----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +-----------------COMP:V-N(in)-----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +-----------------COMP:V-N(in)-----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +-----------------COMP:V-N(in)-----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,muscle) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ +----------------------COMP:V-N(from)----------------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(from) (increase,__SP__) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+-----------------COMP:N-N(from)----------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+-----------------COMP:N-N(from)----------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +------------COMP:N-N(in)-----------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +------------COMP:N-N(in)-----------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-----------------COMP:N-N(from)----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-----------------COMP:N-N(from)----------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------COMP:V-N(in)---------------------------------+ +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +------------COMP:N-N(in)-----------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+-------------SUBJ:V-N------------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +------------COMP:N-N(in)-----------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ +--------SUBJ:V-N--------+ +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,muscle) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-----------------COMP:N-N(from)----------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+-------------SUBJ:V-N------------+--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,mRNA) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +-----------------COMP:N-N(from)----------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | +--SUBJ:V-N--+ | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,__SP__) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+----------------------------------COMP:V-N(in)---------------------------------+ +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+ +-----------------COMP:N-N(from)----------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+--------------------------SUBJ:V-N--------------------------+ +-----------------COMP:N-N(from)----------------+ +----------------------------------COMP:V-N(in)---------------------------------+ +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) COMP:V-N(in) (involve,__SP__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+---COMP:N-N(from)---+ | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) COMP:N-N(from) (mRNA,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +------------COMP:N-N(in)-----------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ +COMP:N-N(fr+ | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(from) (muscle,__SP__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +-----------------COMP:N-N(from)----------------+ | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+COMP:N-N+ | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,muscle) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +-----------------COMP:N-N(from)----------------+ | | | +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-ADJ (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
+----------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+ | +--------------------------SUBJ:V-N--------------------------+ | | +-----------------COMP:N-N(from)----------------+ | | | +------------COMP:N-N(in)-----------+ | | +-------------------APPOS-------------------+ | +---------------------------SUBJ:V-N---------------------------+ +-------COMP:N-N(of)-------+ | | +--------OBJ:V-N-------+ +-------MOD_ATT:N-ADJ------+ | | +-----------OBJ:V-N----------+ | | +-MOD_ATT:N-ADJ+ | | | +-MOD_ATT:N-ADJ+ | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+-COMP:N-N(of)-+ | +MOD_ATT:+COMP:N+ | +--OBJ:V-N-+ | +MOD_AT+ | | | | +MOD_ATT+ | | +MOD_AT+ | | | | | | | | | | | | | | | | | | | | | | | | | Oral administration of __NODE__ ( with a treatment period of 2 weeks ) increases expression of __SP__ __NODE__ mRNA in muscle from __SP__ that involves mutant __SP__ __NODE__ gene ( unspecified homozygous gene mutation ) in __SP__ . MOD_ATT:N-N (administration,oral) COMP:N-N(of) (administration,__NODE__) OBJ:V-N (with,week) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,2) SUBJ:V-N (increase,administration) OBJ:V-N (increase,expression) COMP:V-N(in) (increase,__SP__) COMP:N-N(of) (expression,mRNA) COMP:N-N(in) (expression,muscle) COMP:N-N(from) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (involve,expression) OBJ:V-N (involve,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,mutation) MOD_ATT:N-ADJ (mutation,unspecified) MOD_ATT:N-ADJ (mutation,homozygous) MOD_ATT:N-N (mutation,gene)
